Puma Biotechnology, Inc., a biopharmaceutical company, announced the initiation of its ALISertib in CAncer Phase II trial of alisertib monotherapy for the treatment of...
Puma Biotechnology, Inc. a biopharmaceutical company, announced that the United States Patent and Trademark Office (USPTO) issued a Patent Term Extension Certificate for U.S....
